/ /

CLINICAL

Study offers new insight into pediatric eczemaResearchers have identified the skin phenotype of pediatric atopic dermatitis (AD) — a finding that challenges the notion of filaggrin's central role in the disease.
Advances in pediatric inflammatory skin diseaseExciting research is likely to change treatment for children. Dr. Eichenfield discusses advancements in treating this population.
Phase 3 results demonstrate dupilumab efficacyNew data suggests positive safety and efficacy profile. Further studies need to assess long-term use.
Infant’s disseminated rash is twice misdiagnosedA frustrated mother carries her 2-month-old son into the office for evaluation of a diffuse bright red rash with dramatic hypopigmentation. Scalp, neck, axillary, and diaper areas are involved.
Knowledge of skin microbiome provides insights into dermatological conditionsDirect sequencing data, together with culture data, supplies researchers with information about communities of bacteria and fungi on the skin.
Integrating pharmacy benefit, medical benefit cuts costsHere’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.
Study offers new insight into pediatric eczema
Study offers new insight into pediatric eczemaResearchers have identified the skin phenotype of pediatric atopic dermatitis (AD) — a finding that challenges the notion of filaggrin's central role in the disease.
FDA approves etanercept for pediatric psoriasisThe US Food and Drug Administration (FDA) approval of etanercept for treatment of children with moderate to severe plaque psoriasis will revolutionize the management of psoriasis in children.
More evidence links psoriasis to depression
More evidence links psoriasis to depressionA recent study provides more evidence that patients with psoriasis–even mild cases–face a higher risk of major depression, a finding that could lead dermatologists to alert patients with the condition and even screen them for mental health issues.
October clinical considerations for NPs, PAsThis month, we examine how to recognize Zika virus, a new therapeutic option for AD, and the concept of field cancerization in treating actinic keratosis.

Poll

View Results